Ethan Lippmann
Last active: 12/9/2015

Profile

Dr. Lippmann graduated from the University of Illinois at Urbana-Champaign with a bachelor’s degree in Chemical Engineering in 2006. He next trained as a Dahlke/Hougen graduate fellow in the Department of Chemical Engineering at the University of Wisconsin-Madison where he pioneered the use of human pluripotent stem cells (hPSCs) for constructing in vitro models of the blood-brain barrier. After receiving his Ph.D. in 2012, he worked as an NRSA postdoctoral fellow jointly in the Wisconsin Institute for Discovery (WID) and the Department of Biomedical Engineering, where he developed novel strategies for generating neural cells from hPSCs. In the fall of 2015, Dr. Lippmann joined the Department of Chemical and Biomolecular Engineering at Vanderbilt University. His lab is currently focused on using hPSCs to create representative vascularized CNS constructs for drug screening and disease modeling purposes, as well as isolating novel affinity reagents to target or control cell behavior for therapeutic applications.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm. Lippmann ES, Williams CE, Ruhl DA, Estevez-Silva MC, Chapman ER, Coon JJ, Ashton RS (2015) Stem Cell Reports 4(4): 632-44
    › Primary publication · 25843047 (PubMed) · PMC4400649 (PubMed Central)
  2. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Lippmann ES, Al-Ahmad A, Azarin SM, Palecek SP, Shusta EV (2014) Sci Rep : 4160
    › Primary publication · 24561821 (PubMed) · PMC3932448 (PubMed Central)
  3. Defined human pluripotent stem cell culture enables highly efficient neuroepithelium derivation without small molecule inhibitors. Lippmann ES, Estevez-Silva MC, Ashton RS (2014) Stem Cells 32(4): 1032-42
    › Primary publication · 24357014 (PubMed)
  4. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, Palecek SP, Shusta EV (2012) Nat Biotechnol 30(8): 783-91
    › Primary publication · 22729031 (PubMed) · PMC3467331 (PubMed Central)